Articles From: Industry’s First High-Temperature MEMS Gyroscope Improves Productivity of Oil and Gas Drilling Equipment to INFOBLOX 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Infoblox, Inc. - BLOX


Software Defined Networking (SDN) and Network Function Virtualization (NFV) are taking on a dominant role in Cable and Telecom operator networks as they strive to lead the market and respond dynamically to subscribers’ needs for new services and applications.
Sign-up for Industry’s First Virtualized Ethernet Probe Offers Efficient, Scalable Testing and Diagnostics for Multi-Tenant Environments investment picks
2014/8/19
American IndyCar driver and team owner Ed Carpenter is joining the Interactive Intelligence Foundation for its fourth annual dinner-auction gala to raise funds for charities that foster life improvements for at-risk youth.
Sign-up for IndyCar Driver Ed Carpenter to Speak at Annual Interactive Intelligence Foundation Charity Event investment picks
NEWARK, N.J. , Aug.
Sign-up for Inergetics Announces Additional Distribution at Winn-Dixie Stores investment picks
Innovative Marketing Initiatives to Drive Bikini Ready® Energy Gummies NEWARK, N.J. , Aug.
Sign-up for Inergetics Bikini Ready® Partners with Influenster and Bulu Box™ investment picks
The New York Times calls for the national legalization of cannabis accelerating validation of CBD NEWARK, N.J. , July 29, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI) , a leading developer of nutritional supplements, today announced the successful completion of its first phase towards the formulation of its proprietary line of natural cannabidiol CBD-based nutritional supplements it is developing in partnership with Terra Tech Corp (OCTBB: TRTC). Research shows that cannabinoids have medical application for a range of conditions as varied as epilepsy, glaucoma, osteoporosis, anorexia, Alzheimer's disease and pain treatment.
Sign-up for Inergetics Completes Phase I Development of its Therapeutic CBD Line of Products investment picks
2014/8/5
Innovative Technology and Pharmacokinetic (PK) Studies Lead Path to CBD efficacy.
Sign-up for Inergetics Enters Second Phase of a Three Phase Process to Launch its CBD-Based Supplements investment picks
NEWARK, N.J. , July 23, 2014 /PRNewswire/ -- Inergetics, Inc. (OTCBB: NRTI) , a leading developer of nutritional supplements, is proud to announce that the company will be presenting Martha Stewart™ Essentials, its line of whole-food-based vitamin supplements developed in concert with Martha Stewart herself at Cardinal Health's Retail Business Conference (RBC), the independent pharmacy industry's top tradeshow.
Sign-up for Inergetics to Present Martha Stewart™ Essentials at Cardinal Health's Retail Business Conference in Washington, D.C. investment picks
NEWARK, N.J. , Aug.
Sign-up for Inergetics' Bikini Ready® Lifestyle Brand Gains Distribution at Ross Stores, Inc. investment picks
Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) and International Rectifier Corporation (NYSE: IRF) today announced that they have signed a definitive agreement under which Infineon will acquire International Rectifier for US-Dollar 40 per share in an all-cash transaction valued at approximately US-Dollar 3 billion.
Sign-up for Infineon Technologies AG to Acquire International Rectifier Corporation for US-Dollar 40 per share, approximately US-Dollar 3 billion in cash investment picks
Infinera Corporation (NASDAQ: INFN), provider of Intelligent Transport Networks , today released financial results for the second quarter of 2014 ended June 28, 2014.
Sign-up for Infinera Corporation Reports Second Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201104/60146_infineralogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144874&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for Infinera Introduces Cloud Xpress for the Metro Cloud investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that the company has purchased an option to buy out all future potential royalty payments due to Millennium: The Takeda Oncology Company for sales in oncology of IPI-145, Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma.
Sign-up for Infinity Amends PI3K-Delta, Gamma Agreement with Millennium investment picks
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - - Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. - - Infinity to Host Conference Call Today at 8:30 A.M. ET/7:30 A.M. CT - CAMBRIDGE, Mass.
Sign-up for Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.
Sign-up for Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 5, 2014, at 8:30 a.m. ET.
Sign-up for Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has entered into a master clinical supply agreement with Roche under which Roche will supply Gazyva TM (obinutuzumab) to Infinity for use in planned clinical studies to evaluate the combination of Gazyva and duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with hematologic malignancies, or blood cancers.
Sign-up for Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche investment picks
Shares of Infinity Pharmaceuticals (INFI) soared 46% in premarket trade Wednesday, after the company said it would receive an upfront payment of $275 million from AbbVie (ABBV) as part of a new collaboration to develop and commercialize Infinity's duvelisib, a treatment for blood cancers.
Sign-up for Infinity Pharmaceuticals shares soar after AbbVie collaboration investment picks
BIRMINGHAM, Ala.
Sign-up for Infinity Property And Casualty Corporation Declares Quarterly Dividend investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2014 financial results and ongoing progress with IPI-145 , an oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma.
Sign-up for Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the BMO Capital Markets 3 rd Annual Biotech Corporate Access Day on July 29, 2014.
Sign-up for Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following upcoming conferences: FBR Inaugural Healthcare Conference, Boston, MA, September 3 rd (no presentation or webcast) Morgan Stanley Healthcare Conference 2014, New York, September 8 th , at 11:40 a.m. ET A live webcast of Infinity's presentation at the Morgan Stanley Conference will be accessible on the “investors/media” section of the company's website, www.infi.com , and will be available for 30 days following each event.
Sign-up for Infinity to Participate in Two Conferences in September investment picks
2014/9/27
By Tom Herman Inflation may not sound like a reason to celebrate.
Sign-up for Inflation Could Help You Next Year investment picks
2014/9/29
Insurance firms are making a significant move toward private market assets to diversify against the risks that have traditionally underpinned their businesses, a new BlackRock-commissioned study of insurers with over $6.2 trillion of assets has found.
Sign-up for Inflation Risks and Thirst for Yield Drive Insurers to Private Markets investment picks
2014/9/30
By Min Zeng Prices on inflation-linked Treasury bonds are slipping, in part reflecting concerns that Pacific Investment Management Co.
Sign-up for Inflation-Linked Bond Prices Slip investment picks
2014/7/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133010&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for INFOBLOX 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Infoblox, Inc. - BLOX investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Industry’s First High-Temperature MEMS Gyroscope Improves Productivity of Oil and Gas Drilling Equipment to INFOBLOX 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Infoblox, Inc. - BLOX
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices